2013 Stock of the Year.
Due diligence and buy at the bottom.
One of the co-founders of Amgen recently joined the company's advisory board. He stated that the company's patented MANF technology could be worth billions in future revenues.
#$%$ #$%$. I have 300k shares and when i see some fkers like you, going on NOK board and trying to pump AMBS, i will sell it as soon as possible. FKY
Sentiment: Strong Sell
Patented MANF technology to treat a myriad of diseases. Current focus is on Parkinson's disease.
Get in under four cents today before it gaps higher.